¼ºñ½º »óǰ
¸®¼Ä¡ Á¤º¸
°í°´¼¾ÅÍ
°øÁö»çÇ×
´Ù¿î·Îµå
BONDWEB ½Ã½ºÅÛÀº ²÷ÀÓ¾ø´Â Á¤º¸Çõ½ÅÀ» ÅëÇØ ±ÝÀ¶ ¼±ÁøÈ¿¡ ±â¿©ÇÕ´Ï´Ù.
BONDWEB
º»µåÀ¥Plus
ÃֱٰԽù°
°æÁ¦Á¾ÇÕ´º½º
º¸µµÀÚ·á
½Ã°¡Æò°¡Ç¥
ÁÖ¿ä±Ý¸®
IRS/CRS
½ºÅ©·¦
ÇïÇÁµ¥½ºÅ©
´Ù¿î·Îµå¼¾ÅÍ
°øÁö»çÇ× & ´º½º
ÀÎÀçã±â
ENG
Àü ü
À̵¥Àϸ®
¸Ó´ÏÅõµ¥ÀÌ
´º½ºÇË
¿¬ÇÕ´º½º
¿¬ÇÕÀÎÆ÷¸Æ½º
Çѱ¹°æÁ¦
¸ÅÀϰæÁ¦
¼¿ï°æÁ¦
ÆÄÀ̳½¼È´º½º
º»µåÀ¥
ÀÏÀÚ
Á¦¸ñ
Ãâó
7/14
20:13
¢ßÀ̳ëºôµå·¦, ¿ï»ê Áß±¸ ¡®Ã»³âµðµõÅÍ¡¯ »õ ¿î¿µ»ç¿¡ ¼±Á¤
Çѱ¹°æÁ¦
7/14
20:10
[´Üµ¶]¡®´Ú°ø¡¯ ¼¿ï½Ã¡¦¸ð¾ÆÅ¸¿î ¹®ÅÎ ³·Ãá´Ù
¸ÅÀϰæÁ¦
7/14
20:09
"Çѱ¹¼ 1Á¶7000¾ï ±Ü¾ú´Ù"¡¦¿Ü±¹ÀÎ ¹«¼·°Ô ¾µ¾î´ãÀº "À̰÷"
Çѱ¹°æÁ¦
7/14
20:02
Ư°Ë, ±è°ÇÈñ ´ë¹ý ¼±°í ¿¬±â ½Åû¡¦"ÃÖ¼Ò ÇÑ´Þ ¹Ì·ï´Þ¶ó"
Çѱ¹°æÁ¦
7/14
20:00
[ÁÖ½Ä]SKÇÏ´Ð ±¦È÷ ÆÈ¾Ò³ª¡¦¿ª´ë±Þ ÆÐ´Ð¼¿ µÚ ³ª¿Â "¶æ¹ÛÀÇ Àü¸Á" [ºÐ..
Çѱ¹°æÁ¦
7/14
20:00
»þ³ÚÀÎ ÁÙ ¾Ë¾Ò³×¡¦¹æÄÛ 1020åü »çÀ̼ ÅÍÁø Çѱ¹ ºê·£µå
Çѱ¹°æÁ¦
7/14
20:00
ÄÚÆ®¶ó, °æ±â ºÏºÎ AI Ȱ¿ë ¼öÃ⸶ÄÉÆÃ ¼³¸íȸ °³ÃÖ
À̵¥Àϸ®
7/14
19:54
Ã౸Çùȸ, Çö´ë°¡ ´õºñ ÁÖ½É-¼±¼ö Ãæµ¹ »óȲ ÆÇÁ¤ ³í¶õ¿¡ "Á¤½É"
¿¬ÇÕ´º½º
7/14
19:53
South Korea Eases Biosimilar Approval Requirements, Allowing Waiv..
ÇコÄÚ¸®¾Æ
7/14
19:51
³úÁ¾¾ç ¾Î´Â 3¼¼¾ÆÀÌ ¾ó±¼¿¡ µû±Í ÀÚ±¹ÀÌ¡¦25Â÷·Ê ÇдëÇÑ ¾î¸°ÀÌÁý±³»ç..
¸ÅÀϰæÁ¦
7/14
19:51
ÀÌ ´ëÅë·É, ¿µ±¹ ¾Ø °øÁÖ Á¢°ß¡¦¡°ÇÑ¡¤¿µ ÇØ¾ç Çù·Â ´õ È®´ëµÇ±æ¡±
¸ÅÀϰæÁ¦
7/14
19:48
[ÁÖ½Ä]¡°´ë¸¶ºÒ»ç¶ó´õ´Ï ÀâÁÖó·³ ¿òÁ÷¿©¡±¡¦200¸¸¿øÂ¥¸® ÁÖ½Ä 43%Æø¶ô..
¸ÅÀϰæÁ¦
7/14
19:48
[¼Óº¸] 1¸¸820¿ø vs 1¸¸620¿ø¡¦ÃÖÀúÀÓ±Ý 11Â÷ ¼öÁ¤¾È
Çѱ¹°æÁ¦
7/14
19:48
[¼Óº¸] ³ë 1¸¸820¿ø¡¤»ç 1¸¸620¿ø¡¦ÃÖÀúÀÓ±Ý 11Â÷ ¼öÁ¤¾È
¸ÅÀϰæÁ¦
7/14
19:48
[¼Óº¸] ÃÖÀúÀÓ±Ý 1¸¸820¿ø vs 1¸¸620¿ø¡¦ÃÖÁ¾ °áÁ¤ ÀÓ¹Ú
Çѱ¹°æÁ¦
Àüü : 2232
óÀ½
ÀÌÀü
[6]
[7]
[8]
[9]
[10]
´ÙÀ½
³¡À¸·Î
Ȩ > ¸®¼Ä¡Á¤º¸ >
°æÁ¦Á¾ÇÕ´º½º